The issue of "range bound" is the company keeps dumping stock on the market indirectly through warrant exercise, options and convertible debt. They have been chronically diluting the stock with nothing positive offsetting it. Now let's add 200,000,000 more shares while the daily volume is only 2.1 million shares. If you watch, you can swing the stock $0.10 with a hundred thousand shares -- no dump 10s of million directly or indirectly. They have to payoff $65 million in current payables, ~$55 million in vulture debt and the company is burning over $10 million a month. Also ~$12 million that Amarex claims is past due while they are holding all the company's clinical data. This is all a lot of downward pressure and a BTD is not going to offset all that.
News 
Market Data 
Discover 
